Smart for pills
The US has its first drug with a digital ingestion tracking system. The Abilify MyCite pill contains an embedded ingestible sensor, made by Proteus Digital Health, which records when the patient takes it.
The system works by sending a message from the sensor – the size of a grain of sand and comprising silicon, copper, and magnesium – to a wearable patch, which transmits the data to a mobile app enabling patients to track the ingestion of the medication on their phones. The patch also records activity levels, sleeping patterns, physical activity and heart rate.
The Food and Drug Administration says it “supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers.”
Abilify MyCite is approved for the treatment of schizophrenia and acute treatment of episodes associated with bipolar disorders.